TrademarkDir
KOSEI PHARMA
LIVE

Serial Number

79240740

Owner

Kosei Pharmaceutical Co., Ltd.

Attorney

M. Scott Alprin

Filing Date

May 1, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

KOSEI PHARMA Trademark

Serial Number: 79240740 • Registration: 5836821

KOSEI PHARMA is a trademark filed by Kosei Pharmaceutical Co., Ltd. on May 1, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Kosei Pharmaceutical Co., Ltd. (2 trademarks)

1-12 Higashi Koraibashi
Osaka-shi, Osaka 540-0039 , JP

Entity Type: 03

Trademark Details

Filing Date

May 1, 2018

Registration Date

August 20, 2019

Published for Opposition

June 4, 2019

Cancellation Date

March 6, 2026

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bacterial, cardiovascular, central and peripheral nervous system, diabetic, endocrine, haematological, hormonal, gastrointestinal, gout, immunological, infectious, inflammation and inflammatory, musculoskeletal, neurological, oncological, pain, respiratory, urological and viral diseases and disorders; vaccines; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; empty capsules for pharmaceuticals

Filing History

CANCELLED SECTION 71
Mar 6, 2026 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 20, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 3, 2020 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Dec 14, 2019 FICS
FINAL DISPOSITION PROCESSED
Dec 14, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 20, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 20, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 4, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jun 4, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Jun 1, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 15, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 15, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 15, 2019 NONP
ASSIGNED TO LIE
Apr 25, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 11, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 9, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 9, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 9, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 9, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 8, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 8, 2019 TROA
REFUSAL PROCESSED BY IB
Oct 19, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 29, 2018 RFCS
REFUSAL PROCESSED BY MPU
Sep 29, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 28, 2018 RFCR
NON-FINAL ACTION WRITTEN
Sep 27, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 25, 2018 MAFR
ASSIGNED TO EXAMINER
Sep 19, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 19, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 17, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 13, 2018 REPR

Related Trademarks

More from this Owner

KOSEI PHARMA

KOSEI PHARMA

KOSEI PHARMA

KOSEI PHARMA

KOSEI PHARMA

KOSEI PHARMA